001374421 000__ 02394cam\\2200553\i\4500
001374421 001__ 1374421
001374421 003__ OCoLC
001374421 005__ 20210929003159.0
001374421 007__ he\bmb024bbca
001374421 008__ 191121s2019\\\\dcu\\\\\bb\\\f000\0\eng\c
001374421 019__ $$a1225634744
001374421 035__ $$a(OCoLC)1128186739$$z(OCoLC)1225634744
001374421 040__ $$aGPO$$beng$$erda$$cGPO$$dOCLCF$$dISE
001374421 042__ $$apcc
001374421 043__ $$an-us---
001374421 049__ $$aISEA
001374421 074__ $$a1009-C-01 (MF)
001374421 0860_ $$aY 4.AG 4:S.HRG.115-469
001374421 088__ $$aSerial no. 115-8 (United States. Congress. Senate. Special Committee on Aging)
001374421 1101_ $$aUnited States.$$bCongress.$$bSenate.$$bSpecial Committee on Aging,$$eauthor.
001374421 24510 $$aProgress toward a cure for type I diabetes :$$bresearch and the artificial pancreas : hearing before the Special Committee on Aging, United States Senate, One Hundred Fifteenth Congress, first session, Washington, DC, July 26, 2017.
001374421 24630 $$aResearch and the artificial pancreas
001374421 264_1 $$aWashington :$$bU.S. Government Publishing Office,$$c2019.
001374421 300__ $$aiii, 44 pages ;$$c24 cm.
001374421 336__ $$atext$$btxt$$2rdacontent
001374421 337__ $$amicroform$$bh$$2rdamedia
001374421 338__ $$amicrofiche$$bhe$$2rdacarrier
001374421 4901_ $$aS. hrg. ;$$v115-469
001374421 500__ $$aShipping list no.: 2019-0164-M.
001374421 500__ $$a"Serial no. 115-8."
001374421 504__ $$aIncludes bibliographical references.
001374421 533__ $$aMicrofiche.$$b[Washington, D.C.] :$$cU.S. Government Printing Office,$$d[2019?]$$e1 microfiche : negative
001374421 650_0 $$aDiabetes$$xResearch$$zUnited States.
001374421 650_0 $$aDiabetics$$xTreatment$$zUnited States.
001374421 650_0 $$aArtificial pancreas$$zUnited States.
001374421 650_0 $$aDiabetes in children$$xTreatment$$zUnited States.
001374421 650_0 $$aDrug delivery devices$$zUnited States.
001374421 650_7 $$aArtificial pancreas.$$2fast$$0(OCoLC)fst01744507
001374421 650_7 $$aDiabetes in children$$xTreatment.$$2fast$$0(OCoLC)fst00892216
001374421 650_7 $$aDiabetes$$xResearch.$$2fast$$0(OCoLC)fst00892188
001374421 650_7 $$aDrug delivery devices.$$2fast$$0(OCoLC)fst00898666
001374421 651_7 $$aUnited States.$$2fast$$0(OCoLC)fst01204155
001374421 655_7 $$aLegislative hearings.$$2fast$$0(OCoLC)fst01910825
001374421 655_7 $$aLegislative hearings.$$2lcgft
001374421 77608 $$iPrint version;$$aUnited States. Congress. Senate. Special Committee on Aging.$$tProgress toward a cure for type I diabetes$$w(OCoLC)1089835421
001374421 77608 $$iOnline version;$$aUnited States. Congress. Senate. Special Committee on Aging.$$tProgress toward a cure for type I diabetes$$w(OCoLC)1089948709
001374421 8101_ $$aUnited States.$$bCongress.$$bSenate.$$tS. hrg. ;$$v115-469.
001374421 852__ $$bdfich
001374421 852__ $$bedoc$$hY 4.AG 4:S.HRG.115-469
001374421 85640 $$uhttps://purl.fdlp.gov/GPO/gpo117571
001374421 909CO $$ooai:library.usi.edu:1374421$$pGLOBAL_SET
001374421 980__ $$aBIB
001374421 980__ $$aEGOV
001374421 982__ $$aGovernment E-Resource
001374421 983__ $$aOnline
001374421 994__ $$aC0$$bISE